Jiuqiang Biotech: China International Finance Corporation\'s 2024 Semi-Annual Follow-up Report on Beijing Jiuqiang Biotechnology Co., Ltd.
Jiuqiang Biotech: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2024
Jiuqiang Biotech: Risk Management Plan for Developing Financial Services such as Deposits and Loans at Sinopharm Group Finance Co., Ltd.
Jiuqiang Biotech: Announcement on changing the registered capital and amending the “Articles of Association”
Beijing Strong Biotechnologies, Inc.: Summary Table of Non-Operating Funds Used and Other Related Fund Transactions for the First Half of 2024.
Beijing Strong Biotechnologies, Inc.: Announcement regarding related-party transactions of wholly-owned subsidiaries.
Beijing Strong Biotechnologies, Inc.: Announcement about not reducing the conversion price of "Jiu Qiang Convertible Bonds"
Beijing Strong Biotechnologies, Inc.: Announcement on the expected downward revision conditions of the conversion price for Jiuzhou Convertible Bonds.
Beijing Strong Biotechnologies, Inc.: Announcement on the Completion of the Implementation of Share Repurchase by the Company and Changes in Shareholding
Beijing Strong Biotechnologies, Inc.: Announcement on the conversion of convertible corporate bonds to stocks in Q2 2024.
Beijing Strong Biotechnologies, Inc.: 2022, Beijing Strong Biotechnologies, Inc. issued convertible corporate bonds on the ChiNext market to unspecified buyers. A 2024 tracking rating report was also released.
Beijing Strong Biotechnologies, Inc.: Announcement on obtaining the registration certificate of medical instruments.
Beijing Strong Biotechnologies, Inc.: Growth issued convertible corporate bonds to unspecified investors with interest payable in 2024 notice.
Beijing Strong Biotechnologies, Inc.: China International Finance Co., Ltd.'s Trustee Management Report on Beijing Strong Biotechnologies, Inc.'s Issuance of Convertible Corporate Bonds to Unsolicited Parties (2023).
Beijing Strong Biotechnologies, Inc.: An indicative announcement on the resumption of share conversion of the top nine convertible bonds
Jiuqiang Biotech: Announcement on price adjustments for the top nine debt-to-equity swaps
Jiuqiang Biotech: An indicative announcement on the suspension of share conversion during the implementation of equity distribution
Jiuqiang Biotech: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Jiuqiang Biotech: Legal Opinion of Beijing Zhongzun Law Firm on the 2023 Annual General Meeting of Shareholders of Beijing Jiuqiang Biotechnology Co., Ltd.
Jiuqiang Biotech: Announcement on Obtaining a Medical Device Registration Certificate
No Data